Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: genOway

Market Cap 24.99M 28.79M 23.03M 21.58M 40.32M 2.76B 41.16M 275M 106M 1.33B 108M 106M 4.62B P/E Ratio 2023 *
-
P/E Ratio 2024 -
Enterprise Value 25.61M 29.51M 23.61M 22.12M 41.33M 2.83B 42.19M 282M 109M 1.36B 111M 108M 4.74B EV / Sales 2023
1.64x
EV / Sales 2024 1.28x
Free-Float
79.77%
Yield 2023 *
-
Yield 2024 -
1 day-0.83%
1 week-4.00%
Current month+0.42%
1 month-4.76%
3 months+0.84%
6 months-2.83%
Current year-11.44%
1 week 2.39
Extreme 2.39
2.47
1 month 2.33
Extreme 2.33
2.5
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.5
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 28/02/1999
Director of Finance/CFO - 30/09/2015
Director TitleAgeSince
Director/Board Member - 28/02/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
19/01/22Buy

Chief Executive Officer

12,500 0.1376%
16/11/21Sell

Chief Executive Officer

5,000 0.0553%
12/11/21Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-4.00%-31.23%-38.78% 25.78M
-1.40%+0.12%-14.73%-12.58% 43.68B
+3.50%-4.15%+265.85%+484.30% 30.65B
-0.61%-3.11%+14.00%-12.36% 30.4B
-1.27%-7.02%-0.82%+20.47% 29.31B
-0.66%-5.84%+7.59%+12.76% 24.2B
+2.01%+3.57%+57.15%+128.55% 13.3B
-1.65%-1.08%+7.92%+7.56% 13.21B
+2.77%-1.48% - - 13.03B
+0.68%-1.74%+103.98%+81.60% 12.12B
Average +0.25%-1.88%+45.52%+74.61% 20.99B
Weighted average by Cap. +0.11%-1.65%+51.88%+89.53%

Financials

2023 2024
Net sales 26.51M 30.55M 24.44M 22.9M 42.78M 2.93B 43.67M 292M 113M 1.41B 115M 112M 4.9B 27.53M 31.73M 25.38M 23.78M 44.43M 3.04B 45.35M 303M 117M 1.46B 119M 117M 5.09B
Net income 1.57M 1.81M 1.44M 1.35M 2.53M 173M 2.58M 17.24M 6.67M 83.37M 6.78M 6.64M 290M 1.83M 2.11M 1.69M 1.58M 2.95M 202M 3.02M 20.13M 7.79M 97.37M 7.92M 7.75M 339M
Net Debt 2.97M 3.43M 2.74M 2.57M 4.8M 328M 4.9M 32.69M 12.66M 158M 12.86M 12.58M 550M 623K 718K 574K 538K 1.01M 68.74M 1.03M 6.85M 2.65M 33.13M 2.69M 2.64M 115M
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
148
Date Price Change Volume
11/06/26 2.400 -0.83% 1,224
10/06/26 2.420 -0.41% 2,941
09/06/26 2.430 0.00% 2,067
08/06/26 2.430 -0.82% 3,130
05/06/26 2.450 -2.00% 4,758
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!